LABCORP HOLDINGS INC (LH) Stock Price & Overview

NYSE:LH • US5049221055

Current stock price

256.135 USD
-0.67 (-0.26%)
Last:

The current stock price of LH is 256.135 USD. Today LH is down by -0.26%. In the past month the price decreased by -5.84%. In the past year, price increased by 3.69%.

LH Key Statistics

52-Week Range239.67 - 293.72
Current LH stock price positioned within its 52-week range.
1-Month Range252.375 - 279.71
Current LH stock price positioned within its 1-month range.
Market Cap
21.052B
P/E
15.20
Fwd P/E
12.89
EPS (TTM)
16.85
Dividend Yield
1.12%

LH Stock Performance

Today
-0.26%
1 Week
-3.07%
1 Month
-5.84%
3 Months
-5.42%
Longer-term
6 Months +1.12%
1 Year +3.69%
2 Years +27.53%
3 Years +13.27%
5 Years -3.41%
10 Years +104.92%

LH Stock Chart

LABCORP HOLDINGS INC / LH Daily stock chart

LH Stock Screens

LH currently appears in the following ChartMill screener lists.

LH Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to LH. When comparing the yearly performance of all stocks, LH is a bad performer in the overall market: 69% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

LH Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to LH. LH has an average financial health and profitability rating.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

LH Earnings

On April 30, 2026 LH reported an EPS of 4.25 and a revenue of 3.54B. The company beat EPS expectations (0.8% surprise) and missed revenue expectations (-2.01% surprise).

Next Earnings DateN/A
Last Earnings DateApr 30, 2026
PeriodQ1 / 2026
EPS Reported$4.25
Revenue Reported3.538B
EPS Surprise 0.80%
Revenue Surprise -2.01%

LH Forecast & Estimates

29 analysts have analysed LH and the average price target is 314.19 USD. This implies a price increase of 22.67% is expected in the next year compared to the current price of 256.135.

For the next year, analysts expect an EPS growth of 11.45% and a revenue growth 4.85% for LH


Analysts
Analysts82.76
Price Target314.19 (22.67%)
EPS Next Y11.45%
Revenue Next Year4.85%

LH Index Membership

LH is currently included in the following stock indexes tracked on ChartMill.

LH Financial Highlights

Over the last trailing twelve months LH reported a non-GAAP Earnings per Share(EPS) of 16.85. The EPS increased by 14.39% compared to the year before.


Income Statements
Revenue(TTM)13.95B
Net Income(TTM)876.50M
Industry RankSector Rank
PM (TTM) 6.28%
ROA 4.77%
ROE 10.17%
Debt/Equity 0.6
Chartmill High Growth Momentum
EPS Q2Q%10.68%
Sales Q2Q%5.75%
EPS 1Y (TTM)14.39%
Revenue 1Y (TTM)7.25%

LH Ownership

Ownership
Inst Owners100.01%
Shares82.19M
Float81.84M
Ins Owners0.39%
Short Float %3.96%
Short Ratio5.3

LH Industry Overview

LH operates in the Health Care Services sub-industry within the Health Care sector. This group contains 50 stocks and is scored by ChartMill on both price strength and growth momentum.

Industry Strength Score

46/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.

Industry Growth Score

88/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.

Relative Performance

Each rank shows how many other sub-industries were outperformed over that timeframe.

1 Month Rank
32%
Outperformed 32% of sub-industries
3 Month Rank
54%
Outperformed 54% of sub-industries
6 Month Rank
42%
Outperformed 42% of sub-industries

Industry Fundamentals & Breadth

Members
50
New Highs
10%
New Lows
6%
Average ROE
10%
Average Profit Margin
2.8%
Average Operating Margin
5.2%
Average P/E
42.4
Average Fwd P/E
27.7
Average Debt/Equity
0.8

About LH

Company Profile

LH logo image Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 71,000 full-time employees. The firm operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The firm is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.

Company Info

IPO: 1991-04-24

LABCORP HOLDINGS INC

358 S Main St

Burlington NORTH CAROLINA 27215 US

CEO: Adam H. Schechter

Employees: 66385

LH Company Website

LH Investor Relations

Phone: 18009279800

LABCORP HOLDINGS INC / LH FAQ

What does LABCORP HOLDINGS INC do?

Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 71,000 full-time employees. The firm operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The firm is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.


Can you provide the latest stock price for LABCORP HOLDINGS INC?

The current stock price of LH is 256.135 USD. The price decreased by -0.26% in the last trading session.


Does LABCORP HOLDINGS INC pay dividends?

LABCORP HOLDINGS INC (LH) has a dividend yield of 1.12%. The yearly dividend amount is currently 2.91.


How is the ChartMill rating for LABCORP HOLDINGS INC?

LH has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Should I buy LH stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on LH.


What is LABCORP HOLDINGS INC worth?

LABCORP HOLDINGS INC (LH) has a market capitalization of 21.05B USD. This makes LH a Large Cap stock.


What is the Short Interest ratio of LABCORP HOLDINGS INC (LH) stock?

The outstanding short interest for LABCORP HOLDINGS INC (LH) is 3.96% of its float.